These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. Mestan KK; Gotteiner N; Porta N; Grobman W; Su EJ; Ernst LM J Pediatr; 2017 Jun; 185():33-41. PubMed ID: 28162769 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants. Mariduena J; Ramagopal M; Hiatt M; Chandra S; Laumbach R; Hegyi T J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1517-1522. PubMed ID: 32366142 [TBL] [Abstract][Full Text] [Related]
6. Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia. Kim DH; Shin SH; Kim EK; Kim HS Pregnancy Hypertens; 2018 Jul; 13():148-153. PubMed ID: 30177044 [TBL] [Abstract][Full Text] [Related]
7. Placenta growth factor elevation in the cord blood of premature neonates predicts poor pulmonary outcome. Tsao PN; Wei SC; Su YN; Lee CN; Chou HC; Hsieh WS; Hsieh FJ Pediatrics; 2004 May; 113(5):1348-51. PubMed ID: 15121952 [TBL] [Abstract][Full Text] [Related]
8. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
9. Peptide growth factors in tracheal aspirates of mechanically ventilated preterm neonates. Ambalavanan N; Novak ZE Pediatr Res; 2003 Feb; 53(2):240-4. PubMed ID: 12538781 [TBL] [Abstract][Full Text] [Related]
10. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL; J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432 [TBL] [Abstract][Full Text] [Related]
11. Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia. Hendricks-Muñoz KD; Xu J; Voynow JA Pediatr Pulmonol; 2018 Aug; 53(8):1046-1052. PubMed ID: 29687638 [TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Borghesi A; Massa M; Campanelli R; Bollani L; Tzialla C; Figar TA; Ferrari G; Bonetti E; Chiesa G; de Silvestri A; Spinillo A; Rosti V; Stronati M Am J Respir Crit Care Med; 2009 Sep; 180(6):540-6. PubMed ID: 19574444 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Lassus P; Turanlahti M; Heikkilä P; Andersson LC; Nupponen I; Sarnesto A; Andersson S Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1981-7. PubMed ID: 11734455 [TBL] [Abstract][Full Text] [Related]
14. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates]. Woynarowska M; Rutkowska M; Szamotulska K Med Wieku Rozwoj; 2008; 12(4 Pt 1):933-41. PubMed ID: 19471069 [TBL] [Abstract][Full Text] [Related]
15. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease. Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766 [TBL] [Abstract][Full Text] [Related]
16. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants. Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654 [TBL] [Abstract][Full Text] [Related]
17. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants. Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701 [TBL] [Abstract][Full Text] [Related]
18. Genes Encoding Vascular Endothelial Growth Factor A (VEGF-A) and VEGF Receptor 2 (VEGFR-2) and Risk for Bronchopulmonary Dysplasia. Mahlman M; Huusko JM; Karjalainen MK; Kaukola T; Marttila R; Ojaniemi M; Haataja R; Lavoie PM; Rämet M; Hallman M; Neonatology; 2015; 108(1):53-9. PubMed ID: 25998098 [TBL] [Abstract][Full Text] [Related]
19. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study. Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045 [TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity? Kalra VK; Aggarwal S; Arora P; Natarajan G Pediatr Pulmonol; 2014 Nov; 49(11):1106-11. PubMed ID: 24214578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]